Drug Shortage Report for ENABLEX

Last updated on 2024-02-02 History
Report ID 194549
Drug Identification Number 02273225
Brand name ENABLEX
Common or Proper name ENABLEX
Company Name SEARCHLIGHT PHARMA INC
Market Status MARKETED
Active Ingredient(s) DARIFENACIN
Strength(s) 15MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100 Tablets
ATC code G04BD
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Shortage of an active ingredient.
Anticipated start date 2023-08-01
Actual start date
Estimated end date 2024-07-15
Actual end date
Shortage status Actual shortage
Updated date 2024-02-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1600 RUE NOTRE DAME OUEST, SUITE 312
MONTREAL, QUEBEC
CANADA H3J 1M1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2024-02-02 French Compare
v8 2024-02-02 English Compare
v7 2024-01-11 French Compare
v6 2024-01-11 English Compare
v5 2023-11-01 French Compare
v4 2023-11-01 English Compare
v3 2023-08-02 English Compare
v2 2023-06-09 French Compare
v1 2023-06-09 English Compare

Showing 1 to 9 of 9